Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : son of T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (167)	9/15/1999 2:58:00 PM
From: LLCF	Respond to of 673

Merril Lynch has a biotech conference call in 5 minutes.... DAK

To: RWReeves who wrote (167)	9/15/1999 3:05:00 PM
From: Mike McFarland	Respond to of 673

It looks like you have thought this out rather carefully...so all I can say is happy trades! The most interesting thing I have seen today is that Hoechst is dropping out of Cell Genesys HIV partnership. Modified T-cell gene therapy...not sure what you would call that, adoptive-immuno-gene-therapy? ''Their view is that this program did not meet criteria for a Phase III program,'' Cell Genesys Chief Executive Officer Stephen Sherwin said of Hoecht's decision to pull out. Let's see if I can catch this on a rebound, bought 1000 CEGE at 7 11/16ths (just on paper for me/Mr. GG...) Oh, I cant resist this, 500 INCY at 23 3/8ths--that one too...